Is LAKE or PETV more profitable?

Lakeland Industries has a net margin of -10.87% compared to PetVivo's net margin of -902.82%. Lakeland Industries' return on equity of -6.64% beat PetVivo's return on equity. Company Net Margins Return on Equity Return on Assets Lakeland Industries -10.87% -6.64% -4.13% PetVivo -902.82% -4,813.07% -281.78%

Does the media refer more to LAKE or PETV?

In the previous week, Lakeland Industries had 3 more articles in the media than PetVivo. MarketBeat recorded 4 mentions for Lakeland Industries and 1 mentions for PetVivo. Lakeland Industries' average media sentiment score of 1.04 beat PetVivo's score of 0.00 indicating that Lakeland Industries is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Lakeland Industries 2 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive PetVivo 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts prefer PETV or SKIN?

Beauty Health has a consensus target price of $2.02, suggesting a potential upside of 197.94%. Given Beauty Health's stronger consensus rating and higher probable upside, analysts plainly believe Beauty Health is more favorable than PetVivo. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score PetVivo 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Beauty Health 1 Sell rating(s) 6 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00

Which has stronger earnings & valuation, PETV or SKIN?

Beauty Health has higher revenue and earnings than PetVivo. Beauty Health is trading at a lower price-to-earnings ratio than PetVivo, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio PetVivo $1.05M 23.36 -$10.95M -$0.38 N/A Beauty Health $300.80M 0.29 -$9.52M -$0.17 N/A

Is PETV or SKIN more profitable?

Beauty Health has a net margin of -2.03% compared to PetVivo's net margin of -902.82%. Beauty Health's return on equity of -9.38% beat PetVivo's return on equity. Company Net Margins Return on Equity Return on Assets PetVivo -902.82% -4,813.07% -281.78% Beauty Health -2.03% -9.38% -1.21%

Does the media refer more to PETV or SKIN?

In the previous week, Beauty Health had 8 more articles in the media than PetVivo. MarketBeat recorded 9 mentions for Beauty Health and 1 mentions for PetVivo. Beauty Health's average media sentiment score of 0.74 beat PetVivo's score of 0.00 indicating that Beauty Health is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment PetVivo 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Beauty Health 3 Very Positive mention(s) 5 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts recommend PETV or HSDT?

Solana has a consensus price target of $3.50, suggesting a potential upside of 109.71%. Given Solana's stronger consensus rating and higher probable upside, analysts plainly believe Solana is more favorable than PetVivo. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score PetVivo 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Solana 1 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 1 Strong Buy rating(s) 2.50

Which has stronger valuation & earnings, PETV or HSDT?

PetVivo has higher earnings, but lower revenue than Solana. PetVivo is trading at a lower price-to-earnings ratio than Solana, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio PetVivo $1.05M 23.36 -$10.95M -$0.38 N/A Solana $6.02M 16.19 -$40.89M -$109.67 N/A

Is PETV or HSDT more profitable?

PetVivo has a net margin of -902.82% compared to Solana's net margin of -1,427.15%. Solana's return on equity of -67.57% beat PetVivo's return on equity. Company Net Margins Return on Equity Return on Assets PetVivo -902.82% -4,813.07% -281.78% Solana -1,427.15% -67.57% -24.09%

Does the media favor PETV or HSDT?

In the previous week, Solana had 2 more articles in the media than PetVivo. MarketBeat recorded 3 mentions for Solana and 1 mentions for PetVivo. Solana's average media sentiment score of 1.23 beat PetVivo's score of 0.00 indicating that Solana is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment PetVivo 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Solana 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts rate PETV or PYPD?

PolyPid has a consensus target price of $11.33, suggesting a potential upside of 181.22%. Given PolyPid's stronger consensus rating and higher probable upside, analysts plainly believe PolyPid is more favorable than PetVivo. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score PetVivo 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 PolyPid 1 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.60

Which has stronger valuation & earnings, PETV or PYPD?

PetVivo has higher revenue and earnings than PolyPid. PolyPid is trading at a lower price-to-earnings ratio than PetVivo, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio PetVivo $1.05M 23.36 -$10.95M -$0.38 N/A PolyPid N/A N/A -$34.17M -$1.91 N/A

Is PETV or PYPD more profitable?

PolyPid has a net margin of 0.00% compared to PetVivo's net margin of -902.82%. PolyPid's return on equity of -241.96% beat PetVivo's return on equity. Company Net Margins Return on Equity Return on Assets PetVivo -902.82% -4,813.07% -281.78% PolyPid N/A -241.96% -126.91%

Does the media prefer PETV or PYPD?

In the previous week, PolyPid had 14 more articles in the media than PetVivo. MarketBeat recorded 15 mentions for PolyPid and 1 mentions for PetVivo. PolyPid's average media sentiment score of 0.32 beat PetVivo's score of 0.00 indicating that PolyPid is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment PetVivo 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral PolyPid 3 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts prefer PETV or HYPR?

Hyperfine has a consensus target price of $1.78, suggesting a potential upside of 93.63%. Given Hyperfine's stronger consensus rating and higher probable upside, analysts clearly believe Hyperfine is more favorable than PetVivo. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score PetVivo 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Hyperfine 1 Sell rating(s) 2 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.33

Which has higher valuation and earnings, PETV or HYPR?

PetVivo has higher earnings, but lower revenue than Hyperfine. Hyperfine is trading at a lower price-to-earnings ratio than PetVivo, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio PetVivo $1.05M 23.36 -$10.95M -$0.38 N/A Hyperfine $11.40M 8.02 -$35.57M -$0.41 N/A

Is PETV or HYPR more profitable?

Hyperfine has a net margin of -226.88% compared to PetVivo's net margin of -902.82%. Hyperfine's return on equity of -98.83% beat PetVivo's return on equity. Company Net Margins Return on Equity Return on Assets PetVivo -902.82% -4,813.07% -281.78% Hyperfine -226.88% -98.83% -67.09%

Does the media refer more to PETV or HYPR?

In the previous week, Hyperfine had 3 more articles in the media than PetVivo. MarketBeat recorded 4 mentions for Hyperfine and 1 mentions for PetVivo. Hyperfine's average media sentiment score of 0.96 beat PetVivo's score of 0.00 indicating that Hyperfine is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment PetVivo 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Hyperfine 1 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

PetVivo (PETV) Competitors

$0.65 +0.01 (+1.20%)

As of 11:59 AM Eastern

Compare

PETV vs. LAKE, SKIN, HSDT, PYPD, and HYPR

Should you buy PetVivo stock or one of its competitors? MarketBeat compares PetVivo with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with PetVivo include Lakeland Industries (LAKE), Beauty Health (SKIN), Solana (HSDT), PolyPid (PYPD), and Hyperfine (HYPR). These companies are all part of the "medical equipment" industry.

How does PetVivo compare to Lakeland Industries?

Lakeland Industries (NASDAQ:LAKE) and PetVivo (NASDAQ:PETV) are both small-cap medical equipment companies, but which is the better investment? We will compare the two companies based on the strength of their risk, institutional ownership, profitability, earnings, dividends, media sentiment, valuation and analyst recommendations.

Lakeland Industries currently has a consensus price target of $16.00, suggesting a potential upside of 51.80%. Given Lakeland Industries' stronger consensus rating and higher probable upside, equities research analysts clearly believe Lakeland Industries is more favorable than PetVivo.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Lakeland Industries	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40
PetVivo	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Lakeland Industries has a beta of 1.45, indicating that its stock price is 45% more volatile than the broader market. Comparatively, PetVivo has a beta of 1.23, indicating that its stock price is 23% more volatile than the broader market.

In the previous week, Lakeland Industries had 3 more articles in the media than PetVivo. MarketBeat recorded 4 mentions for Lakeland Industries and 1 mentions for PetVivo. Lakeland Industries' average media sentiment score of 1.04 beat PetVivo's score of 0.00 indicating that Lakeland Industries is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Lakeland Industries	2 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
PetVivo	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

PetVivo has lower revenue, but higher earnings than Lakeland Industries. Lakeland Industries is trading at a lower price-to-earnings ratio than PetVivo, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Lakeland Industries	$193.32M	0.54	-$25.31M	-$2.13	N/A
PetVivo	$1.05M	23.36	-$10.95M	-$0.38	N/A

71.7% of Lakeland Industries shares are owned by institutional investors. Comparatively, 24.5% of PetVivo shares are owned by institutional investors. 3.4% of Lakeland Industries shares are owned by company insiders. Comparatively, 10.8% of PetVivo shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Lakeland Industries has a net margin of -10.87% compared to PetVivo's net margin of -902.82%. Lakeland Industries' return on equity of -6.64% beat PetVivo's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Lakeland Industries	-10.87%	-6.64%	-4.13%
PetVivo	-902.82%	-4,813.07%	-281.78%

Summary

Lakeland Industries beats PetVivo on 11 of the 16 factors compared between the two stocks.

How does PetVivo compare to Beauty Health?

PetVivo (NASDAQ:PETV) and Beauty Health (NASDAQ:SKIN) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, earnings, media sentiment, dividends, analyst recommendations, valuation, risk and profitability.

Beauty Health has higher revenue and earnings than PetVivo. Beauty Health is trading at a lower price-to-earnings ratio than PetVivo, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
PetVivo	$1.05M	23.36	-$10.95M	-$0.38	N/A
Beauty Health	$300.80M	0.29	-$9.52M	-$0.17	N/A

Beauty Health has a consensus target price of $2.02, suggesting a potential upside of 197.94%. Given Beauty Health's stronger consensus rating and higher probable upside, analysts plainly believe Beauty Health is more favorable than PetVivo.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
PetVivo	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Beauty Health	1 Sell rating(s)	6 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

24.5% of PetVivo shares are owned by institutional investors. Comparatively, 93.3% of Beauty Health shares are owned by institutional investors. 10.8% of PetVivo shares are owned by insiders. Comparatively, 40.3% of Beauty Health shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

PetVivo has a beta of 1.23, indicating that its stock price is 23% more volatile than the broader market. Comparatively, Beauty Health has a beta of 1.08, indicating that its stock price is 8% more volatile than the broader market.

In the previous week, Beauty Health had 8 more articles in the media than PetVivo. MarketBeat recorded 9 mentions for Beauty Health and 1 mentions for PetVivo. Beauty Health's average media sentiment score of 0.74 beat PetVivo's score of 0.00 indicating that Beauty Health is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
PetVivo	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Beauty Health	3 Very Positive mention(s)	5 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Beauty Health has a net margin of -2.03% compared to PetVivo's net margin of -902.82%. Beauty Health's return on equity of -9.38% beat PetVivo's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
PetVivo	-902.82%	-4,813.07%	-281.78%
Beauty Health	-2.03%	-9.38%	-1.21%

Summary

Beauty Health beats PetVivo on 13 of the 16 factors compared between the two stocks.

How does PetVivo compare to Solana?

PetVivo (NASDAQ:PETV) and Solana (NASDAQ:HSDT) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their profitability, risk, dividends, valuation, media sentiment, analyst recommendations, earnings and institutional ownership.

PetVivo has higher earnings, but lower revenue than Solana. PetVivo is trading at a lower price-to-earnings ratio than Solana, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
PetVivo	$1.05M	23.36	-$10.95M	-$0.38	N/A
Solana	$6.02M	16.19	-$40.89M	-$109.67	N/A

24.5% of PetVivo shares are held by institutional investors. Comparatively, 18.6% of Solana shares are held by institutional investors. 10.8% of PetVivo shares are held by insiders. Comparatively, 14.4% of Solana shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

In the previous week, Solana had 2 more articles in the media than PetVivo. MarketBeat recorded 3 mentions for Solana and 1 mentions for PetVivo. Solana's average media sentiment score of 1.23 beat PetVivo's score of 0.00 indicating that Solana is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
PetVivo	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Solana	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

PetVivo has a beta of 1.23, indicating that its share price is 23% more volatile than the broader market. Comparatively, Solana has a beta of 1.03, indicating that its share price is 3% more volatile than the broader market.

PetVivo has a net margin of -902.82% compared to Solana's net margin of -1,427.15%. Solana's return on equity of -67.57% beat PetVivo's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
PetVivo	-902.82%	-4,813.07%	-281.78%
Solana	-1,427.15%	-67.57%	-24.09%

Solana has a consensus price target of $3.50, suggesting a potential upside of 109.71%. Given Solana's stronger consensus rating and higher probable upside, analysts plainly believe Solana is more favorable than PetVivo.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
PetVivo	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Solana	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.50

Summary

Solana beats PetVivo on 11 of the 17 factors compared between the two stocks.

How does PetVivo compare to PolyPid?

PetVivo (NASDAQ:PETV) and PolyPid (NASDAQ:PYPD) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, analyst recommendations, profitability, risk, dividends, earnings, media sentiment and valuation.

24.5% of PetVivo shares are held by institutional investors. Comparatively, 26.5% of PolyPid shares are held by institutional investors. 10.8% of PetVivo shares are held by company insiders. Comparatively, 24.7% of PolyPid shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

PetVivo has a beta of 1.23, indicating that its share price is 23% more volatile than the broader market. Comparatively, PolyPid has a beta of 1.4, indicating that its share price is 40% more volatile than the broader market.

In the previous week, PolyPid had 14 more articles in the media than PetVivo. MarketBeat recorded 15 mentions for PolyPid and 1 mentions for PetVivo. PolyPid's average media sentiment score of 0.32 beat PetVivo's score of 0.00 indicating that PolyPid is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
PetVivo	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
PolyPid	3 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

PetVivo has higher revenue and earnings than PolyPid. PolyPid is trading at a lower price-to-earnings ratio than PetVivo, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
PetVivo	$1.05M	23.36	-$10.95M	-$0.38	N/A
PolyPid	N/A	N/A	-$34.17M	-$1.91	N/A

PolyPid has a net margin of 0.00% compared to PetVivo's net margin of -902.82%. PolyPid's return on equity of -241.96% beat PetVivo's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
PetVivo	-902.82%	-4,813.07%	-281.78%
PolyPid	N/A	-241.96%	-126.91%

PolyPid has a consensus target price of $11.33, suggesting a potential upside of 181.22%. Given PolyPid's stronger consensus rating and higher probable upside, analysts plainly believe PolyPid is more favorable than PetVivo.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
PetVivo	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
PolyPid	1 Sell rating(s)	0 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.60

Summary

PolyPid beats PetVivo on 11 of the 15 factors compared between the two stocks.

How does PetVivo compare to Hyperfine?

PetVivo (NASDAQ:PETV) and Hyperfine (NASDAQ:HYPR) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their valuation, profitability, institutional ownership, media sentiment, earnings, risk, dividends and analyst recommendations.

PetVivo has higher earnings, but lower revenue than Hyperfine. Hyperfine is trading at a lower price-to-earnings ratio than PetVivo, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
PetVivo	$1.05M	23.36	-$10.95M	-$0.38	N/A
Hyperfine	$11.40M	8.02	-$35.57M	-$0.41	N/A

Hyperfine has a consensus target price of $1.78, suggesting a potential upside of 93.63%. Given Hyperfine's stronger consensus rating and higher probable upside, analysts clearly believe Hyperfine is more favorable than PetVivo.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
PetVivo	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Hyperfine	1 Sell rating(s)	2 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.33

Hyperfine has a net margin of -226.88% compared to PetVivo's net margin of -902.82%. Hyperfine's return on equity of -98.83% beat PetVivo's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
PetVivo	-902.82%	-4,813.07%	-281.78%
Hyperfine	-226.88%	-98.83%	-67.09%

In the previous week, Hyperfine had 3 more articles in the media than PetVivo. MarketBeat recorded 4 mentions for Hyperfine and 1 mentions for PetVivo. Hyperfine's average media sentiment score of 0.96 beat PetVivo's score of 0.00 indicating that Hyperfine is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
PetVivo	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Hyperfine	1 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

PetVivo has a beta of 1.23, indicating that its share price is 23% more volatile than the broader market. Comparatively, Hyperfine has a beta of 1.4, indicating that its share price is 40% more volatile than the broader market.

24.5% of PetVivo shares are held by institutional investors. Comparatively, 15.0% of Hyperfine shares are held by institutional investors. 10.8% of PetVivo shares are held by insiders. Comparatively, 26.3% of Hyperfine shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Summary

Hyperfine beats PetVivo on 11 of the 16 factors compared between the two stocks.

Get PetVivo News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding PETV and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

PETV vs. The Competition

Export

Metric	PetVivo	Surgical & medical instruments Industry	Medical Sector	NASDAQ Exchange
Market Cap	$24.44M	$38.05M	$7.04B	$12.05B
Dividend Yield	N/A	1.08%	2.66%	8.55%
P/E Ratio	-1.44	16.24	27.33	23.54
Price / Sales	23.36	24.29	576.65	107.02
Price / Cash	N/A	18.86	49.60	59.05
Price / Book	-21.67	8.46	10.07	5.99
Net Income	-$10.95M	-$20.60M	$3.60B	$336.19M
7 Day Performance	-6.15%	-4.84%	-1.70%	-2.49%
1 Month Performance	-26.14%	-12.87%	-4.31%	-5.53%
1 Year Performance	-17.72%	-18.93%	19.41%	13.17%

PetVivo Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
PETV PetVivo	N/A	$0.65 +1.2%	N/A	-16.6%	$24.44M	$1.05M	N/A	20	Gap Down
LAKE Lakeland Industries	2.3782 of 5 stars	$11.43 -0.2%	$16.00 +40.0%	-27.2%	$113M	$192.65M	N/A	2,600	News Coverage Positive News
SKIN Beauty Health	3.5367 of 5 stars	$0.84 +2.7%	$2.02 +139.4%	-60.3%	$106.47M	$300.80M	N/A	1,030	Gap Down
HSDT Solana	3.4784 of 5 stars	$1.69 -1.5%	$3.50 +107.7%	-80.4%	$99.84M	$6.02M	N/A	30	News Coverage Positive News
PYPD PolyPid	2.8823 of 5 stars	$5.37 +3.5%	$11.67 +117.3%	+3.0%	$99.04M	N/A	N/A	80	Short Interest Increase Gap Up

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:PETV) was last updated on 7/29/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

PetVivo (PETV) Competitors

PETV vs. LAKE, SKIN, HSDT, PYPD, and HYPR

How does PetVivo compare to Lakeland Industries?

Summary

How does PetVivo compare to Beauty Health?

Summary

How does PetVivo compare to Solana?

Summary

How does PetVivo compare to PolyPid?

Summary

How does PetVivo compare to Hyperfine?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

PETV vs. The Competition

PetVivo Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

PetVivo (PETV) Competitors

PETV vs. LAKE, SKIN, HSDT, PYPD, and HYPR

How does PetVivo compare to Lakeland Industries?

Do analysts recommend LAKE or PETV?

Which has more volatility & risk, LAKE or PETV?

Does the media refer more to LAKE or PETV?

Which has better valuation & earnings, LAKE or PETV?

Do institutionals and insiders have more ownership in LAKE or PETV?

Is LAKE or PETV more profitable?

Summary

How does PetVivo compare to Beauty Health?

Which has stronger earnings & valuation, PETV or SKIN?

Do analysts prefer PETV or SKIN?

Do institutionals and insiders have more ownership in PETV or SKIN?

Which has more risk & volatility, PETV or SKIN?

Does the media refer more to PETV or SKIN?

Is PETV or SKIN more profitable?

Summary

How does PetVivo compare to Solana?

Which has stronger valuation & earnings, PETV or HSDT?

Do insiders and institutionals hold more shares of PETV or HSDT?

Does the media favor PETV or HSDT?

Which has more risk and volatility, PETV or HSDT?

Is PETV or HSDT more profitable?

Do analysts recommend PETV or HSDT?

Summary

How does PetVivo compare to PolyPid?

Do insiders and institutionals hold more shares of PETV or PYPD?

Which has more volatility and risk, PETV or PYPD?

Does the media prefer PETV or PYPD?

Which has stronger valuation & earnings, PETV or PYPD?

Is PETV or PYPD more profitable?

Do analysts rate PETV or PYPD?

Summary

How does PetVivo compare to Hyperfine?

Which has higher valuation and earnings, PETV or HYPR?

Do analysts prefer PETV or HYPR?

Is PETV or HYPR more profitable?

Does the media refer more to PETV or HYPR?

Which has more risk and volatility, PETV or HYPR?

Do insiders and institutionals hold more shares of PETV or HYPR?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

PETV vs. The Competition

PetVivo Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools